Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies designed to treat immunology and inflammatory (I&I) indications by guiding T cells to overcome autoimmunity and inflammatory diseases
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies designed to treat immunology and inflammatory (I&I) indications by guiding T cells to overcome autoimmunity and inflammatory diseases.